Advertisement

Topics

Companies Related to "The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial" [Most Relevant Company Matches] RSS

00:41 EDT 24th October 2018 | BioPortfolio

Here are the most relevant search results for "The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial" found in our extensive corporate database of over 50,000 company records.

Showing "Comparison Outcomes Antibiotic Drugs Appendectomy CODA Trial" Companies 1–25 of 2,300+

Relevant

CoDa Therapeutics, Inc.

CoDa Therapeutics is a clinical stage biotechnology company focused on developing novel targeted therapies that address major unmet medical needs in inflammation, wound-healing and tissue repair. The company is pioneering a new field of science: gap junction modulation, using a new class of therapeutics that can modulate wound responses and reduce inflammation. CoDa has two open INDs and has comp...


Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...

CODA Automotive


NovaDel Pharma Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly re...

PolyMedix, Inc.

PolyMedix is a publicly traded biotechnology company focused on the development of novel drugs and biomaterials for the treatment of serious acute cardiovascular disorders and infectious diseases. PolyMedix uses a rational drug design approach to create non-peptide small molecule drug candidates and polymers that mimic the activity of proteins. PMX-60056, ...

Microbiotix, Inc.

Microbiotix, Inc. is a privately held, product-focused biopharmaceutical company engaged in the research and development of novel small molecule, anti-infective drugs that address commercially significant medical markets. The company currently has four novel compound series in research and development. Microbiotix currently has in development MBX 500, the first antibiotic that targets the DNA po...

Health Outcomes Sciences

Health Outcomes Sciences is propelling the practice of precision medicine through its patented content enablement platform, ePRISM®, which translates scientific models into automated evidence-based decision support solutions. By helping health and life science organizations -- as well as allied technology partners -- deliver the power of personalized pr...

Biopharmacopae

For centuries plants have been a very important source of medications. Less than 5% of the 300,00 plant species have ever been investigated for their medicinal properties. An estimated one-quarter of the prescription drugs contain active ingredients derived from plants. Widely used drugs from plant extracts include the antibiotic, immunosuppressant, and the anti-anti cancer agents. Global over the...

Clinical Research Advantage, Inc.

Tempe, Ariz.-based Clinical Research Advantage, Inc. (CRA) is a provider of a range of research services to pharmaceutical companies and clinical research organizations (CROs). As a leading trial management organization (TMO), CRA operates from 29 sites across 12 geographic markets nationwide, helping trial sponsors bring drugs to market more quickly and e...

Otonomy, Inc.

Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. The company's core technology is a sustained release formulation developed for optimal delivery of drugs from a single intratympanic (IT) injection. Broad applicability of this delivery and formulation technology has already been established across a number of therapeuti...

Ipsat Therapies Oy

Ipsat Therapies Ltd is a Finnish biotechnology company developing its proprietary IPSAT™ (“Intestinal Protection System in Antibiotic Treatment”) family of products for the prevention of hospital infections and antibiotic resistance

AdvanDx, Inc.

AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens that cause critical infections in hospitalized patients. Our mission is to improve antibiotic decision-making and patient outcomes while limiting unnecessary and inappropriate antibiotic use and reducing healthcare costs.

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to combat the increasing number of antibiotic-resistant infections worldwide. The Company has two short-term strategic objectives:To identify and formulate proprietary topical Phage preparations from dis...

NEOSPORIN(R)

NEOSPORIN® Original First Aid Antibiotic Ointment, from the #1 Doctor-recommended brand, provides long-lasting infection protection and kills more types of infectious bacteria in laboratory tests than even the leading topical prescription antibiotic. Plus, NEOSPORIN® Original First Aid Antibiotic Ointment and a bandage help heal minor wounds four days faster than a bandage alone and may help min...

PolyMedix Inc.

PolyMedix is a publicly traded emerging biotechnology company focused the development of novel drugs and biomaterials for the treatment of infectious diseases and acute cardiovascular disorders. PolyMedix’s compounds are based on biomimetics: non-peptide small molecule drug candidates that mimic the activity of proteins. The Company’s antibioti...

Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II many dreaded infectious diseases such as diphtheria, pneumonia, syphilis, and tuberculosis disappeared almost overnight. However all is not well with the antibiotics story. The bacterial pathogens are f...

Mpex Pharmaceuticals

Mpex Pharmaceuticals is focused on the discovery and development of new anti-bacterial drugs that meet the growing clinical need created by multi-drug resistant bacterial pathogens. It is well documented that antibiotic resistance is a growing, serious problem in both the hospital and community setting. Mpex's approach is to improve the activity of existing antibiotics by utilizing methods and pot...

OMNICON Company

Manufacturers of the OMNICON Zone Reader for Antibiotic Potency Testing - Zones of Inhibition - Fisher Lilly Antibiotic Zone Reader - Peni Cylinder - Peni Cylinder Dispenser - Large Plate - NUNC Bio-Assay Dish

Trial By Fire Solutions

Trial By Fire Solutions is a global leader in web-based clinical trial management solutions and develops innovative applications to improve planning, execution and tracking of clinical studies. Since the release of its SimpleCTMS product, Trial By Fire Solutions has been providing affordable eClinical solutions to teams of all sizes.

Provisio, Inc

Headquartered in Nashville, TN, Provisio, Inc. develops technologies and services that enhance clinical trial processes. Its flagship solution, iTrials, automates and streamlines the way drug trial candidates are identified, notified and enrolled. iTrials breaks the traditional paradigm associated with lengthy and costly clinical trial enrollment. Leveraging iTrials "unique-to-industry" data wareh...

Innate Pharmaceuticals AB

Innate Pharmaceuticals' business concept is to develop bactericidal drugs that meet important medical needs and for which there is a large market. Our business is based on groundbreaking research findings in the fields of innate immunity and microbiology. Innate will work to identify candidate drugs (chemical compounds) using its own technology platforms and then develop these to the preliminary c...

Social Solutions Global, Inc.

Social Solutions Global, Inc., creators of Efforts to Outcomes (ETO®) software, equips over 16,000 programs with web-based data-tracking and outcomes-oriented case management tools to improve results, simplify reporting requirements and improve efficiencies in delivering services across agencies and funding streams. Unlike traditional CRM and Case Manag...

Trial Acceleration Institute, Inc.

Trial Acceleration Institute collaborates with the entire spectrum of clinical trial stakeholders to improve study cycle times. Assisting stakeholders with actionable resolutions to their specific cycle time challenges (from protocol feasibility to patient retention) via the identification and initiation of best-of-class, third-party solutions is the primary mission of Trial Acceleration Institute...

Protox Therapeutics Inc.

Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platforms, therapeutic candidates are generated by engineering the naturally occurring toxins, Pseudomonas exotoxin and proaerolysin. These drug...


More From BioPortfolio on "The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks